Loading...
Last submissions
-
Olivier Baud, Loic Sentilhes, Moreno Ursino, Muriel Doret-Dion, Corinne Alberti, et al.. Survival without severe neonatal morbidity after antenatal betamethasone dose reduction: a post hoc analysis of a randomized non-inferiority trial. American Journal of Obstetrics and Gynecology, 2024, Online ahead of print. ⟨10.1016/j.ajog.2024.02.002⟩. ⟨hal-04689204⟩
-
Peter Wolf, Benjamin Marty, Khaoula Bouazizi, Nadjia Kachenoura, Céline Piedvache, et al.. Response to Letter to the Editor from Soghomonian: “Epicardial and Pericardial Adiposity Without Myocardial Steatosis in Cushing Syndrome”. Journal of Clinical Endocrinology and Metabolism, 2022, 107 (1), pp.e443-e444. ⟨10.1210/clinem/dgab678⟩. ⟨hal-03942111⟩
-
Carole Faviez, Xiaoyi Chen, Nicolas Garcelon, Mohamad Zaidan, Katy Billot, et al.. Objectivizing issues in the diagnosis of complex rare diseases: lessons learned from testing existing diagnosis support systems on ciliopathies. BMC Medical Informatics and Decision Making, 2024, 24 (1), pp.134. ⟨10.1186/s12911-024-02538-8⟩. ⟨hal-04685782⟩
-
Silvia Calderazzo, Sergey Tarima, Carissa Reid, Nancy Flournoy, Tim Friede, et al.. Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions. Statistics in Biopharmaceutical Research, 2023, pp.1-17. ⟨10.1080/19466315.2023.2211023⟩. ⟨hal-04336804⟩
-
Christina Yap, Olga Solovyeva, Johann de Bono, Jan Rekowski, Dhrusti Patel, et al.. Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance. BMJ - British Medical Journal, In press, pp.e076387. ⟨10.1136/bmj-2023-076387⟩. ⟨hal-04336824⟩